Statera Therapeutics, Inc.statera-therapeutics.com
New Haven, CT, USA
Statera’s patented technology, Spatiotemporally Tuned Particles (STP), adds targeting and temporal control to the otherwise free floating drug agents. In encapsulating drug agents in STP, we can achieve optimized, sequential delivery to specific cell targets. STP has been shown to supersede the efficacy of the current standard of combinatorial drug delivery.Inaccurate data? Flag it here.
Open jobs at Statera Therapeutics, Inc.